Skip to main content
. 2016 Sep 7;7(41):66569–66585. doi: 10.18632/oncotarget.11892

Figure 4. Clinicopathologic parameters from the 40 melanoma whole genome samples.

Figure 4

The difference in promoter (cluster) mutation load between mutant and wildtype cases for a. BRAF, b. NRAS and c. NF1 mutations are shown. d. shows the relationship between promoter (cluster) mutation load and nonsynonymous mutation load.